Vyleesi Archives • NCK Pharma

Case Study: Vyleesi™ (Bremelanotide Injection) for HSDD in Premenopausal Women

Posted on24 Jun 2019

TagsAmag, Amag Terminate Ferumoxytol Accord for EU, new drug approval, Vyleesi

Comments0

U.S. Food and Drug Administration (FDA) has approved Vyleesi™ (bremelanotide injection), a melanocortin receptor agonist, to treat acquired, generalized hypoactive sexual desire...